Navigation Links
Gersten Savage Expands IP Practice With Partner Jason Lief
Date:9/24/2009

NEW YORK, Sept. 24 /PRNewswire/ -- Intellectual property attorney Jason Lief has joined Gersten Savage LLP as a partner, the firm announced. He is co-chair of the firm's intellectual property practice with partner James Fornari. Lief's practice focuses on patent and intellectual property litigation and counseling, with a particular concentration on the pharmaceutical industry.

Lief has successfully represented clients in several dozen major patent litigations, including Hatch-Waxman cases involving billion-dollar pharmaceutical products and matters concerning other cutting-edge technologies. His extensive trial and litigation experience includes trying patent infringement, validity and enforceability issues before United States federal judges and juries; arguing before the U.S. Court of Appeals for the Federal Circuit; and managing and conducting all aspects of discovery, including foreign court appearances pursuant to the Hague Convention.

He has represented major pharmaceutical companies and has handled matters spanning organic chemistry, biotechnology, antibodies, combinatorial chemistry, RNAi technology, antibiotics, anti-depressants, anti-retroviral and anti-ulcer medicines, sustained-release medicines, drug-stabilization, polymers, advanced battery systems, detergents and deodorant technologies.

"We are very pleased to welcome Jason on board. He brings extensive experience to the firm, particularly in the area of pharmaceutical patents and IP," said Jay Kaplowitz, Gersten Savage managing partner. "Together with IP practice co-chair Jim Fornari, we can provide clients with expertise in a wide array of intellectual property matters."

Prior to joining Gersten Savage, Lief was a partner with McDermott, Will & Emery. Previously, he was a partner with Morgan Lewis & Bockius. He began his career as an associate and then a partner at Hopgood, Calimafde,
'/>"/>

SOURCE Gersten Savage LLP
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Dynatronics Expands Nationwide Direct Sales Force by 25 Percent
2. AmeriCares Expands Medical Assistance Across the United States
3. Gerresheimer Expands in the Global Pharmaceutical Plastic Business
4. Abbott Expands Use of Sustainable Packaging as Part of Global Environmental Efforts
5. Health Advocate, Inc. Expands Headquarters
6. TheraCare Expands Services to Offer Free Home Care to Qualifying Area Veterans and Spouses
7. SIRO Clinpharm Expands Operations in Europe
8. Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology
9. GfK Asia Expands into Regional Optics Industry Following Partnership with Singapore Opticianry Practitioners (SOP)
10. YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide
11. CareTech Expands Relationship With Marietta Memorial Hospital With Five-Year Total IT Services Management Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... feature is by Devon Herrick, PhD, Senior Fellow at ... often assume they have little control over how much ... cannot be scheduled, doctors prescribe treatments and employers provide ... However, there are many overlooked ways to trim your ... ,, Cut your prescription costs: ...
(Date:12/17/2009)... The National Council on Disability ... JW Marriott Houston, 5150 Westheimer, Houston, TX, beginning at ... at 11:00 a.m. on Thursday, January 21, 2010. This ... believes it is vital to hear from communities around ... for people with disabilities. This meeting will provide another ...
(Date:12/17/2009)... MA Brandeis University selected Jay and Maureen Neitz, the ... use of gene therapy to treat vision disorders, as ... in Vision Sciences. , The award is funded by ... gift from Brandeis graduates Jay Pepose ,75 and Susan ... graduate research fellowships in vision science. , The Neitzes, ...
(Date:12/17/2009)... the particle might someday ease accompanying lung infections , , ... severe pneumonia when infected with the swine flu virus, ... why. , A key to the severity of the ... (TH17), which helps the immune system fight off germs ... in swine-flu patients at 10 Spanish hospitals last summer ...
(Date:12/17/2009)... Studies Important ,for the R&D Informatics Industry, , ... ... Cambridge Healthtech Institute is pleased to announce the participation of ... R&D Informatics Systems conference to be held on February 3-5, ... CA. This meeting has been integrated in the Informatics Channel ...
Breaking Medicine News(10 mins):Health News:Six Ways to Slash Your Health Costs 2Health News:Six Ways to Slash Your Health Costs 3Health News:Six Ways to Slash Your Health Costs 4Health News:National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities 2Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 3
... to provide additional modality integrationsINDIANAPOLIS, March 9 ... pleased to announce the worldwide release of its ... Key features of this release include integrated ECG ... Hemodynamic system. Synapse ProSolv cardiovascular 4.0.1 will ...
... Improvement Plus to Provide Information on Medicare Advantage ... Farmers MarketCOLUMBIA, S.C., March 9 A series ... Medicare beneficiaries with chronic illness maintain a healthy ... Plans designed for their unique needs will be ...
... National Commander of the Disabled American Veterans begins a ... for budget reform legislation to ensure sufficient, timely and ... urging them to reject a contentious proposal that would ... from the government,s side of the ledger to insurance ...
... the latest findings in laboratory, translational and clinical cancer ... therapeutic approaches, as well as strides being made in ... the best advantage of the meeting,s scientific abstracts and ... will be available online at www.aacr.org on Friday, March ...
... Treat Osteosarcoma in More Than 20 YearsIRVINE, Calif., March ... IDMI ) today announced that the European Commission ... (mifamurtide, L-MTP-PE) for the treatment of patients with non-metastatic, ... that typically affects children and young adults. The ...
... author reviews the consequencesROCHESTER, Minn., March 9 ... the treating physician recommends discharge, the consequences may ... the need for readmission, according to a review ... Proceedings. Additionally, the article examines the effect of ...
Other Medicine News:Health News:ProSolv Releases New Cardiovascular Software 2Health News:ProSolv Releases New Cardiovascular Software 3Health News:Free Seminars Offered to South Carolina Seniors with Diabetes and Other Chronic Illnesses 2Health News:Disabled Veterans Leader Presses Issues with Key Lawmakers 2Health News:IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma 2Health News:IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma 3Health News:IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma 4Health News:IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma 5Health News:Patients Being Discharged Against Medical Advice 2Health News:Patients Being Discharged Against Medical Advice 3
(Date:12/17/2009)... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced preliminary ... weeks for the first dose cohort, 200 mg bid, in ... pegylated interferon and ribavirin (SOC) in HCV patients. 56% ... virus (<15 IU/ml) at week 4, known as R ... to 20% of patients receiving placebo plus SOC. ...
(Date:12/17/2009)... -- Decision Resources, one of the world,s leading ... healthcare issues, finds that over 70 percent of ... need for diabetes drugs with novel mechanisms of ... a high need for additional DPP-IV inhibitors. Both ... glucose lowering ability and physicians in particular say ...
(Date:12/17/2009)... CARMIEL, Israel, Dec. 17 Protalix BioTherapeutics, ... appointment of Sandra Lauterbach to Vice President, Sales ... U.S. based position, Ms. Lauterbach will be responsible ... activities for taliglucerase alfa in accordance with the ... as well as any other products that emerge ...
Breaking Medicine Technology:ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 2ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 3ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 4ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 5ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 6ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 7Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 2Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 2Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 4Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 1Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 2Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 3Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 4AssureRx Adds New CEO 12542 1AssureRx Adds New CEO 12542 2RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment 48282 1RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment 48282 2RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment 48282 3
... American Society of Breast Surgeons and American College of Radiation ... ... SUNNYVALE, Calif., June 24 Xoft, Inc. today announced,the launch and ... Brachytherapy patient registry,under oversight from three national physician societies, the American,Brachytherapy ...
... Managers, DALLAS, June 23 Employers and ... role in preventing their,workers from suffering crippling or ... at U.S. Preventive Medicine, the leader in,disease prevention., ... U.S. Preventive Medicine,says it,s not uncommon for heart ...
Other Medicine Technology:First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 2First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 3First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies 4U.S. Preventive Medicine: Employers Can Help Workers Avoid Heart Attacks 2U.S. Preventive Medicine: Employers Can Help Workers Avoid Heart Attacks 3
Rapid, visual assay for the presumptive qualitative detection of Respiratory Syncytial Virus (RSV) directly from nasopharyngeal specimens in neonatel and pediatric patients....
Rapid immunochromatographic membrane test for RSV. Accepts nasopharyngeal washes, aspirates, and swabs....
A direct enzyme immunoassay for detection of gr. A rotavirus in fecal specimens....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: